ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
GlycoMimetics Inc

GlycoMimetics Inc (GLYC)

0.2731
0.0043
(1.60%)
Closed July 03 4:00PM
0.2765
0.0034
( 1.24% )
Pre Market: 6:10AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.2765
Bid
0.275
Ask
0.2765
Volume
7,895
0.00 Day's Range 0.00
0.235 52 Week Range 3.5299
Market Cap
Previous Close
0.2731
Open
-
Last Trade
1
@
0.2765
Last Trade Time
06:53:04
Financial Volume
-
VWAP
-
Average Volume (3m)
4,746,011
Shares Outstanding
64,464,412
Dividend Yield
-
PE Ratio
-0.47
Earnings Per Share (EPS)
-0.57
Revenue
10k
Net Profit
-36.9M

About GlycoMimetics Inc

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
GlycoMimetics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLYC. The last closing price for GlycoMimetics was $0.27. Over the last year, GlycoMimetics shares have traded in a share price range of $ 0.235 to $ 3.5299.

GlycoMimetics currently has 64,464,412 shares outstanding. The market capitalization of GlycoMimetics is $17.41 million. GlycoMimetics has a price to earnings ratio (PE ratio) of -0.47.

GLYC Latest News

GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Company exploring path forward for uproleselan in multiple AML settings based on observed efficacy results, including clinically meaningful results in primary refractory AML, and significant...

GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024

GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced that...

GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Study of uproleselan combined with chemotherapy did not meet its primary endpoint of overall survival in the intent to treat population Adverse events were consistent with known side effect...

GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00050.181159420290.2760.2980.264112904150.27932829CS
40.01053.947368421050.2660.4380.23599345280.31737192CS
12-2.2535-89.07114624512.532.530.23547460110.40155957CS
26-2.6835-90.65878378382.963.52990.23523662800.62178112CS
52-1.4235-83.73529411761.73.52990.23512378690.69665597CS
156-2.0035-87.87280701752.284.160.2357231341.24890854CS
260-11.4735-97.646808510611.7513.410.2356813882.15029717CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLGNQualigen Therapeutics Inc
$ 0.3281
(87.06%)
16.38M
STSSSharps Technology Inc
$ 0.307
(33.48%)
7.76M
SLSSELLAS Life Sciences Group Inc
$ 1.38
(21.05%)
5
SONMSonim Technologies Inc
$ 0.6473
(17.54%)
164.56k
MDWDMediWound Limited
$ 17.00
(17.16%)
32.04k
BTFXValkyrie Bitcoin Futures Leveraged Strategy ETF
$ 21.57
(-20.38%)
106
JEWLAdamas One Corporation
$ 0.377
(-18.31%)
46.54k
MSSMaison Solutions Inc
$ 1.11
(-15.91%)
9.01k
ELWSEarlyworks Co Ltd
$ 1.95
(-14.85%)
4
ZCARZoomcar Holdings Inc
$ 0.1596
(-12.79%)
650.39k
MAXNMaxeon Solar Technologies Ltd
$ 0.1979
(14.00%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.328
(87.00%)
16.38M
STSSSharps Technology Inc
$ 0.307
(33.48%)
7.76M
PRTGPortage Biotech Inc
$ 0.172
(-4.71%)
3.43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.45
(3.07%)
2.72M

GLYC Discussion

View Posts
Sierra20 Sierra20 2 days ago
Bankruptcy proceedings next. You been warned. Check out my latest post.
πŸ‘οΈ0
hondaboost hondaboost 1 week ago
GLYC was $3.5 in Jan. Institutions and mutual funds holding 50 million shares at dollars, out of 64 million OS.
👍️ 1
hondaboost hondaboost 1 week ago
GLYC, Chief Medical Officer bought 310,000 shares at $0.26 at open market on June 21. He must know something.


https://www.otcmarkets.com/filing/html?id=17638385&guid=RXO-kWK48IECJth
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 week ago
GLYC: Article here ---
https://www.defenseworld.net/2024/06/25/glycomimetics-inc-nasdaqglyc-insider-edwin-rock-buys-190000-shares.html#google_vignette
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 week ago
you usually post the bottom charts before they go
πŸ‘οΈ0
tw0122 tw0122 1 week ago
Hitting .43s looking good
πŸ‘οΈ0
Sierra20 Sierra20 1 week ago
Delisting letter coming. You have been warned.
πŸ‘οΈ0
glenn1919 glenn1919 1 week ago
GLYC............................https://stockcharts.com/h-sc/ui?s=GLYC&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
subslover subslover 2 weeks ago
Nice insider buys here = https://www.otcmarkets.com/filing/html?id=17638385&guid=NwO-kFXCNX90B3h
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
GLYC new low
πŸ‘οΈ0
spindog spindog 2 months ago
Well? Good thing i held off on taking a position….
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
Gotta wait it out
πŸ‘οΈ0
spindog spindog 2 months ago
Hopefully the FDA will give GLYC the the green light after reviewing phase 3 data in June
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
GLYC under $2
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
GLYC under $4
πŸ‘οΈ0
willlbone willlbone 1 year ago
Dilution.
πŸ‘οΈ0
INFINITI INFINITI 1 year ago
Reversal
πŸ‘οΈ0
TechandBio TechandBio 2 years ago
Picked up a few heavy racks of shares under 2.95 today.


$GLYC
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
GLYC: Hey!!!! WHAT???? (HA-HA!!)
πŸ‘οΈ0
makinezmoney makinezmoney 2 years ago
$GLYC: The chart is screaming bullflag breakout on 100day chart

Now at 2.50


Perfect BULL FLAG.


NICE


GO $GLYC
πŸ‘οΈ0
TommyBoyTrader9460 TommyBoyTrader9460 2 years ago
$GLYC Crazy runner here..on watch to see if it continues as insider bought a ton of shares..

https://stocktwits.com/soll/message/497100283

https://stockcharts.com/c-sc/sc?s=GLYC&p=D&b=5&g=0&i=0&r=1668953354914
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
THANKS!
πŸ‘οΈ0
gail gail 2 years ago
yup and congrats on your other runner.
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
GO-GO-GO-GLYC!!!

PS: Hey, Girl, tap my latest POSTS behind @GRND --- what a SPECTACLE that one is!!!! (I grabbed their WARRANTS!!)

πŸ‘οΈ0
gail gail 2 years ago
looking good here.
πŸ‘οΈ0
gail gail 2 years ago
wow, new highs hitting right now!
πŸ‘οΈ0
gail gail 2 years ago
and back to 2 bucks. lets see what tomorrow brings.
πŸ‘οΈ0
gail gail 2 years ago
boing, and back up she goes.
πŸ‘οΈ0
gail gail 2 years ago
manipulation bringing it …

..

down but lets see what happens.
πŸ‘οΈ0
gail gail 2 years ago
here we go, breaking 2 bucks big time now.
πŸ‘οΈ0
gail gail 2 years ago
its time to break 2 bucks and really move like it did in the past.
πŸ‘οΈ0
1hot toddy 1hot toddy 2 years ago
WOW WOW WOW CHIEF MEDICAL OFFICIER BOUGHT 200,000 SHARES $$$

he went from 0 shares to 200000 in two days. 2- 100000 shares buys 2 days

now 4 employees have bought shares.
πŸ‘οΈ0
1hot toddy 1hot toddy 2 years ago
WOOOOOOOOOOOOOOOOOW 63000 SHARE BUY $$$$$$$$$$$$$$$$

employees are buying toooooooooo
πŸ‘οΈ0
1hot toddy 1hot toddy 2 years ago
3 HUGE INSIDE BUYS BY 3 PEOPLE. 19K, 20K AND 25K $$$$$$$$$$$$$$$$

1.06/1.29 UP UP AND AWAY
πŸ‘οΈ0
willlbone willlbone 2 years ago
Back to 99 cents.
πŸ‘οΈ0
MfridgeV2 MfridgeV2 3 years ago
Agreed. Things looking up. Load up while no one else wants it. ;)
πŸ‘οΈ0
fishhunter fishhunter 3 years ago
Now is but time. The gap has filled, weak hands are out, corporate path is correct.
πŸ‘οΈ0
mining101 mining101 3 years ago
Depends at what level - if back to 2s first it’s a big loss till then
πŸ‘οΈ0
stockguard stockguard 3 years ago
The Investment Case For GlycoMimetics
https://seekingalpha.com/article/4389595-investment-case-for-glycomimetics
πŸ‘οΈ0
whytestocks whytestocks 4 years ago
News; $GLYC GlycoMimetics Program Data to be Highlighted Via Three Oral Presentations and Two Posters at 62nd American Society of Hematology Annual Meeting and Exposition

Data highlight the importance of early intervention with E-selectin inhibitors to disrupt inflammatory mechanisms driving acute vaso-occlusive crisis (VOC) in sickle cell disease (SCD) Additional presentations highlight multiple E-selectin inhibition strategies and their pot...

In case you are interested GLYC - GlycoMimetics Program Data to be Highlighted Via Three Oral Presentations and Two Posters at 62nd American Society of Hematology Annual Meeting and Exposition
πŸ‘οΈ0
fishhunter fishhunter 4 years ago
Great buy at this price. I own a ton of it.
πŸ‘οΈ0
whytestocks whytestocks 4 years ago
News; $GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) Meeting

- Data highlight the importance of early intervention with fast-acting E-selectin inhibitors to disrupt the underlying inflammatory mechanisms driving acute vaso-occlusive crisis (VOC) - Abstracts for two of GlycoMimetics’ wholly-owned product candidates, rivipansel and...

In case you are interested GLYC - New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) Meeting
πŸ‘οΈ0
420man 420man 4 years ago
No brainer here.. Buy and wait for run to 8's or higher. GL
πŸ‘οΈ0
TheFinalCD TheFinalCD 4 years ago
https://ih.advfn.com/stock-market/NASDAQ/glycomimetics-GLYC/stock-news/82651418/new-efficacy-and-biomarker-data-from-rivipansel-ph
πŸ‘οΈ0
Jwit56 Jwit56 4 years ago
This looks good. Surely this'll bring a lot of growth
πŸ‘οΈ0
whytestocks whytestocks 5 years ago
News: $GLYC GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Chief Executive Officer Rachel King will provide a company overview at the Piper Jaffrey 31 st Annual Healthcare Conference in New York, New York, which takes place on December 3, 2019. Ms. King’s presentation is scheduled for 1...

In case you are interested GLYC - GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019
πŸ‘οΈ0
The1andonlyt The1andonlyt 5 years ago
New article out on GLYC https://stocksnewswire.com/2019/08/16/glycomimetics-inc-nasdaq-glyc-is-it-ready-to-bounce-after-big-drop-in-price/
πŸ‘οΈ0
@LiftedCapital @LiftedCapital 5 years ago
LONG 2.88 YESTERDAY!!! BOOOOOOOOOOOMAGE
πŸ‘οΈ0
@LiftedCapital @LiftedCapital 5 years ago
GLYC GLAD IM IN.
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $GLYC Video Chart 08-05-2019 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock